Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' EICHINGER S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pabinger, I; Grafenhofer, H; Kaider, A; Ilic, A; Eichinger, S; Quehenberger, P; Husslein, P; Mannhalter, C; Lechner, K
      Preeclampsia and fetal loss in women with a history of venous thromboembolism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    2. Heis-Vahidi-Fard, N; Forberg, E; Eichinger, S; Chott, A; Lechner, K; Gisslinger, H
      Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study

      ANNALS OF HEMATOLOGY
    3. Endler, G; Kyrle, PA; Eichinger, S; Exner, M; Mannhalter, C
      Multiplexed mutagenically separated PCR: Simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C67TT) variants

      CLINICAL CHEMISTRY
    4. Kyrle, PA; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Schneider, B; Weltermann, A; Speiser, W; Lechner, K; Eichinger, S
      High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.

      NEW ENGLAND JOURNAL OF MEDICINE
    5. Kyrle, PA; Eichinger, S
      High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    6. Eichinger, S; Kyrle, PA; Pabinger, I; Lechner, K
      The risk of recurrent venous thromboembolic disease - implications for treatment

      ACUTE PULMONARY EMBOLISM
    7. Rintelen, C; Mannhalter, C; Lechner, K; Eichinger, S; Kyrle, PA; Papagiannopoulos, M; Schneider, B; Pabinger, I
      No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene

      BLOOD COAGULATION & FIBRINOLYSIS
    8. Eichinger, S; Weltermann, A; Philipp, K; Hafner, E; Kaider, A; Kittl, EM; Brenner, B; Mannhalter, C; Lechner, K; Kyrle, PA
      Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden

      THROMBOSIS AND HAEMOSTASIS
    9. Eichinger, S; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Mannhalter, C; Stumpflen, A; Schneider, B; Lechner, K; Kyrle, PA
      The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene

      THROMBOSIS AND HAEMOSTASIS
    10. Male, C; Lechner, K; Eichinger, S; Kyrle, PA; Kapiotis, S; Wank, H; Kaider, A; Pabinger, I
      Clinical significance of lupus anticoagulants in children

      JOURNAL OF PEDIATRICS
    11. Eichinger, S; Knechtl, C
      Eichinger-Oder-Knechtl, Monocoque, Schretter Apartment, Vienna

      ARCHITECTURAL DESIGN
    12. KYRLE PA; MANNHALTER C; BEGUIN S; STUMPFLEN A; HIRSCHL M; WELTERMANN A; STAIN M; BRENNER B; SPEISER W; PABINGER I; LECHNER K; EICHINGER S
      CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE

      Arteriosclerosis, thrombosis, and vascular biology
    13. WELTERMANN A; EICHINGER S; KYRLE PA
      A NOVEL IMMUNOASSAY FOR THE QUANTIFICATION OF HUMAN TISSUE FACTOR-BINDING TO ACTIVATED FACTOR-VII

      Blood coagulation & fibrinolysis
    14. HELLAN M; KUHNEL E; SPEISER W; LECHNER K; EICHINGER S
      FAMILIAL LUPUS ANTICOAGULANT - A CASE-REPORT AND REVIEW OF THE LITERATURE

      Blood coagulation & fibrinolysis
    15. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    16. EICHINGER S; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; STAIN M; SCHNEIDER B; PABINGER I; LECHNER K; KYRLE PA
      HYPERHOMOCYSTEINEMIA IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    17. WELTERMANN A; MITTERBAUER GJ; MITTERBAUER M; HATTEY E; SPEISER W; GISSLINGER H; KNOBL P; EICHINGER S
      DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)

      Wiener Klinische Wochenschrift
    18. WEKERLE T; EICHINGER S; MAIER A; WRBA F; MOSCHL P
      INTRAHEPATIC SPLENIC TISSUE IN A PATIENT WITH RECURRENT IDIOPATHIC THROMBOCYTOPENIC PURPURA

      Surgery
    19. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
      RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR INCREASES LEVELS OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    20. WENGER G; SCHIENLE M; BELLERMANN J; ACKLIN B; MULLER J; EICHINGER S; MULLER G
      SELF-ALIGNED PACKAGING OF AN 8X8 INGAASP-INP SPACE SWITCH

      IEEE journal of selected topics in quantum electronics
    21. KYRLE PA; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; SPEISER W; WELTERMANN A; KAIDER A; PABINGER I; LECHNER K; EICHINGER S
      LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    22. KYRLE PA; EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; SCHNEIDER B; MANNHALTER C; MELICHART M; TRAXLER G; WELTERMANN A; SPEISER W; LECHNER K
      PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    23. EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; SCHNEIDER B; MANNHALTER C; MINAR E; LECHNER K; KYRLE PA
      THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT FACTOR-V-LEIDEN

      Thrombosis and haemostasis
    24. KYRLE PA; BROCKMEIER J; WELTERMANN A; EICHINGER S; SPEISER W; LECHNER K; EICHLER HG
      INHIBITION RATHER THAN ENHANCEMENT OF HEMOSTATIC SYSTEM ACTIVATION DURING INITIATION OF ORAL ANTICOAGULANT TREATMENT

      Thrombosis and haemostasis
    25. EICHINGER S; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; PABINGER I; HERKNER K; SCHNEIDER B; LECHNER K; KYRLE PA
      HYPERHOMOCYSTEINEMIA (H-HC) IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM (VTE) IN MALE-PATIENTS

      Thrombosis and haemostasis
    26. MALE C; KAPIOTIS S; EICHINGER S; KYRLE PA; LECHNER K
      CLINICAL-SIGNIFICANCE AND COURSE OF LUPUS ANTICOAGULANTS IN CHILDREN

      Thrombosis and haemostasis
    27. WELTERMANN A; KYRLE PA; EICHINGER S
      QUANTIFICATION OF HUMAN TISSUE FACTOR (TF) BINDING TO RECOMBINANT FACTOR VIIA (RVIIA)

      Thrombosis and haemostasis
    28. KYRLE PA; EICHINGER S; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; PABINGER I; SPEISER W; SCHNEIDER B; LECHNER K
      HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS WITH HYPERHOMOCYSTEINEMIA (H-HC)

      Thrombosis and haemostasis
    29. RINTELEN C; PABINGER I; LECHNER K; EICHINGER S; KYRLE PA; MANNHALTER C
      NO EVIDENCE FOR AN INCREASE OF THE RISK OF VENOUS THROMBOSIS IN PATIENTS WITH FACTOR-V-LEIDEN BY THE HOMOZYGOUS MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE

      Thrombosis and haemostasis
    30. EICHINGER S; BRENNER B; PHILIPP K; PUTZ M; SCHUCHTER K; BAUER K; KITTL E; KAIDER A; WELTERMANN A; LECHNER K; KYRLE PA
      MARKED COAGULATION ACTIVATION DURING PREGNANCY WITHOUT EVIDENCE OF VENOUS THROMBOEMBOLISM (VTE)

      Thrombosis and haemostasis
    31. RINTELEN C; SCHARRER I; KLINKE S; MANNHALTER C; EICHINGER S; KYRLE PA; LECHNER K; PABINGER I
      HIGH PREVALENCE OF STILLBIRTHS IN WOMEN HOMOZYGOUS FOR FACTOR-V-LEIDEN MUTATION

      Thrombosis and haemostasis
    32. RUZICKA K; KAPIOTIS S; QUEHENBERGER P; HANDLER S; HORNYKEWYCZ S; MICHITSCH A; HUBER K; CLEMENS D; SUSAN M; PABINGER I; EICHINGER S; JILMA B; SPEISER W
      EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS

      Thrombosis research
    33. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
      RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR AUGMENTS MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA

      Blood
    34. GSCHWANDTNER ME; EICHINGER S; HUTTER D; KORNINGER L; LECHNER K; PANZER S; PABINGER I
      LUPUS ANTICOAGULANT AND THROMBOEMBOLISM - EVALUATION OF FIBRINOGEN, NATURAL INHIBITORS AND MOLECULAR MARKERS OF THROMBOSIS

      Blood coagulation & fibrinolysis
    35. SCHIENLE M; WENGER G; EICHINGER S; MULLER J; STOLL L; MULLER G
      A 1X8 INP INGAASP OPTICAL MATRIX SWITCH WITH LOW INSERTION LOSS AND HIGH CROSSTALK SUPPRESSION/

      Journal of lightwave technology
    36. WENGER G; SCHIENLE M; BELLERMANN J; HEINBACH M; EICHINGER S; MULLER J; ACKLIN B; STOLL L; MULLER G
      A COMPLETELY PACKAGED STRICTLY NONBLOCKING 8X8 OPTICAL MATRIX SWITCH ON INP INGAASP/

      Journal of lightwave technology
    37. BAUER KA; EICHINGER S; MANNUCCI PM; ROSENBERG RD
      DETERMINANTS OF COAGULATION ACTIVATION IN HUMANS

      Haemostasis
    38. MELICHART M; KYRLE PA; EICHINGER S; RINTELEN C; MANNHALTER C; PABINGER I
      THROMBOTIC TENDENCY IN 75 SYMPTOMATIC, UNRELATED PATIENTS WITH APC RESISTANCE

      Wiener Klinische Wochenschrift
    39. BUDKA H; URBANITS S; LIBERSKI PP; EICHINGER S; POPOWKRAUPP T
      SUBACUTE MEASLES-VIRUS ENCEPHALITIS - A NEW AND FATAL OPPORTUNISTIC INFECTION IN A PATIENT WITH AIDS

      Neurology
    40. RINTELEN C; PABINGER I; LECHNER K; EICHINGER S; KYRLE PA; MANNHALTER C
      HOMOZYGOUS C-]T MUTATION IN THE METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) GENE DOES NDT INCREASE THE RISK FOR VENOUS THROMBOSIS IN PATIENTS WITH THE FACTOR-V LEIDEN MUTATION

      Blood
    41. EICHINGER S; WOLZT M; SCHNEIDER B; NIESZPAURLOS M; HEINRICHS H; LECHNER K; EICHLER HG; KYRLE PA
      EFFECTS OF RECOMBINANT HIRUDIN (R-HIRUDIN, HBW-023) ON COAGULATION AND PLATELET ACTIVATION IN-VIVO - COMPARISON WITH UNFRACTIONATED HEPARINAND A LOW-MOLECULAR-WEIGHT HEPARIN PREPARATION (FRAGMIN)

      Arteriosclerosis, thrombosis, and vascular biology
    42. OBRIEN TR; DIAMONDSTONE L; FRIED MW; ALEDORT LM; EICHINGER S; EYSTER ME; HILGARTNER MW; WHITE G; DIBISCEGLIE AM; GOEDERT JJ
      IDIOPATHIC CD4-LYMPHOCYTOPENIA IN HIV SERONEGATIVE MEN WITH HEMOPHILIA AND SEX PARTNERS OF HIV-SEROPOSITIVE MEN( T)

      American journal of hematology
    43. EICHINGER S; PABINGER I; SCHNEIDER B; STUMPFLEN A; HIRSCHL C; BIALONCZYK C; MELICHART M; RINTELEN C; LECHNER K; KYRTE PA
      THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM (VTE) - THE PREDICTIVE VALUE OF DETERMINATION OF ACTIVATED PROTEIN-C (APC) - RESISTANCE AND OF MONITORING MOLECULAR MARKERS OF THROMBOSIS

      Thrombosis and haemostasis
    44. KRONER BL; GOEDERT JJ; BLATTNER WA; WILSON SE; CARRINGTON MN; MANN DL; OBRIEN SJ; WILLOUGHBY A; KESSEL W; DONFIELD SM; MCKINLAY SM; ALEDORT LM; ARKIN S; EYSTER ME; PATTISHALL EG; HILGARTNER MW; KONKLE B; WHITE GC; COHEN AR; BRAY GL; LUBAN N; KESSLER CM; RAGNI MV; LEDERMAN MM; LEISSINGER C; SIROIS P; MANCOJOHNSON M; DEMOERLOOSE P; MAHE A; HATZAKIS A; MANDALAKI T; SCHRAMM W; EICHINGER S; STINGL G; GOMPERTS ED; HOOTS WK; LOVELAND KA; KISKER CT; STEHBENS AA; CONTANT CF; HUSZTI H; SWINDELLS S; MANGOS J; WARRIER I; SHAPIRO AD; DAVIGNON GF; WICKLUND BM; WINKLER C
      CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS

      AIDS
    45. EICHINGER S; MANNUCCI PM; TRADATI F; ARBINI AA; ROSENBERG RD; BAUER KA
      DETERMINANTS OF PLASMA FACTOR VIIA LEVELS IN HUMANS

      Blood
    46. EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; FORBERG E; SCHNEIDER B; RINTELEN C; LECHNER K; KYRLE PA
      THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM (VTE) AFTER DISCONTINUATION OF ORAL ANTICOAGULANTS (OAC) IN PATIENTS WITHOUT AND WITH FACTOR-V(FV) LEIDEN AND THE PREDICTIVE VALUE OF A MOLECULAR MARKER OF THROMBOSIS

      Blood
    47. GISSLINGER H; RINTELEN C; MANNHALTER C; PABINGER I; GEISSLER K; KNOBL P; EICHINGER S; LECHNER K
      FACTOR-V LEIDEN MUTATION IS NOT A MAJOR CAUSE OF THROMBOTIC TENDENCY IN ESSENTIAL THROMBOCYTHEMIA (ET) AND POLYCYTHEMIA-VERA (PV)

      Blood
    48. WENGER G; STOLL L; WEISS B; SCHIENLE M; MULLERNAWRATH R; EICHINGER S; MULLER J; ACKLIN B; MULLER G
      DESIGN AND FABRICATION OF MONOLITHIC OPTICAL SPOT SIZE TRANSFORMERS (MOSTS) FOR HIGHLY EFFICIENT FIBER-CHIP COUPLING

      Journal of lightwave technology
    49. EICHINGER S; WOLZT M; NIESZPAURLOS M; SCHNEIDER B; LECHNER K; EICHLER HG; KYRLE PA
      EFFECTS OF A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN(R)) AND OF UNFRACTIONATED HEPARIN ON COAGULATION ACTIVATION AT THE SITE OF PLUG FORMATION IN-VIVO

      Thrombosis and haemostasis
    50. PABINGER I; SCHNEIDER B; SCHARRER I; HACHWUNDERLE V; LECHNER K; EICHINGER S; KYRLE PA; VINAZZER H; LAMMLE B; DEMARMELSBIASIUTTI F; TILSNER V; MARX G; SEIFRIED E; GABELMANN A; ASPOCK G; FISCHER M; HALBMAYER WM
      THROMBOTIC RISK OF WOMEN WITH HEREDITARY ANTITHROMBIN-III-DEFICIENCY,PROTEIN C-DEFICIENCY AND PROTEIN S-DEFICIENCY TAKING ORAL-CONTRACEPTIVE MEDICATION

      Thrombosis and haemostasis
    51. PABINGER I; KYRLE PA; HEISTINGER M; EICHINGER S; WITTMANN E; LECHNER K
      THE RISK OF THROMBOEMBOLISM IN ASYMPTOMATIC PATIENTS WITH PROTEIN-C AND PROTEIN-S DEFICIENCY - A PROSPECTIVE COHORT STUDY

      Thrombosis and haemostasis
    52. GOEDERT JJ; GARVEY L; HILGARTNER MW; BLATT PM; ALEDORT LM; COHEN AR; KESSLER CM; WHITE GC; MANDALAKI T; COOK RA; MANCOJOHNSON MJ; SCHRAMM W; LEISSINGER CA; RAGNI MV; EICHINGER S; LEDERMAN MM; BRAY GL; BOSSER C; WILSON SE; EYSTER ME
      RISK OF HIV-INFECTION AND AIDS IN WOMEN AND GIRLS WITH COAGULATION DISORDERS

      AIDS
    53. GOEDERT JJ; COHEN AR; KESSLER CM; EICHINGER S; SEREMETIS SV; RABKIN CS; YELLIN FJ; ROSENBERG PS; ALEDORT LM
      RISKS OF IMMUNODEFICIENCY, AIDS, AND DEATH RELATED TO PURITY OF FACTOR-VIII CONCENTRATE

      Lancet
    54. GREENGARD JS; EICHINGER S; GRIFFIN JH; BAUER KA
      VARIABILITY OF THROMBOSIS AMONG HOMOZYGOUS SIBLINGS WITH RESISTANCE TO ACTIVATED PROTEIN-C DUE TO AN ARG-]GLN MUTATION IN THE GENE FOR FACTOR-V

      The New England journal of medicine
    55. EICHINGER S; WOLZT M; EICHLER HG; HEINRICHS H; LECHNER K; KYRLE PA
      EFFECTS OF RECOMBINANT HIRUDIN (R-HIRUDIN) ON COAGULATION AND PLATELET ACTIVATION IN-VIVO - COMPARISON TO UNFRACTIONATED HEPARIN (UFH) AND LOW-MOLECULAR-WEIGHT HEPARIN (LMWH)

      Blood
    56. EICHINGER S; MANNUCCI PM; TRADATI F; ARBINI AA; ROSENBERG RD; BAUER KA
      DETERMINANTS OF PLASMA FACTOR-VIIA LEVELS IN HUMANS

      Blood
    57. EICHINGER S; NIESZPAURLOS M; SCHNEIDER B; WOLZT M; PABINGER I; EICHLER HG; LECHNER K; KYRLE PA
      EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND UNFRACTIONATED HEPARIN (UFH) ON COAGULATION AND PLATELET ACTIVATION AT THE SITE OF PLUG FORMATION

      Thrombosis and haemostasis
    58. EICHINGER S; WOLZT M; EICHLER HG; LECHNER K; KYRLE PA
      EFFECTS OF A LOW-MOLECULAR-WEIGHT HEPARIN (LMWH, FRAGMIN(R) AND OF UNFRACTIONATED HEPARIN (UFH) ON COAGULATION AND PLATELET ACTIVATION IN-VIVO

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 07:21:56